{"SPADE_N_15468": {"Sequence Information": {"Peptide Name": "Lanthipeptide Marinsedin", "Sequence": "FSSSFPDQNTSMICCVLK", "Sequence Length": 18, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer"], "Binding Target": "1. Lipid Bilayer", "Source": "1. Marinicella sediminis", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Discovery and Characterization of Marinsedin, a New Class II Lanthipeptide Derived from Marine Bacterium Marinicella sediminis F2T", "Pubmed ID": "35293716", "Reference": "ACS Chem Biol. 2022;17:785-790", "Author": "Han Y, Wang X, Zhang Y, Huo L", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/35293716"}], "Mass": 2007.31, "PI": 5.82, "Net Charge": 0, "Hydrophobicity": 0.28, "Frequent Amino Acids": "SCF", "Absent Amino Acids": "AEGHORUWY", "Basic Residues": 1, "Acidic Residues": 1, "Hydrophobic Residues": 8, "Polar Residues": 10, "Positive Residues": 1, "Negative Residues": 1, "SPADE ID": "SPADE_N_15468", "Similar Sequences": [{"SPADE_ID": "SPADE_N_14116", "Similarity": 0.5, "Sequence": "EEKLDPICVAKCVLKCGKKPWCLTKCVAACVL"}], "Hemolytic Activity": "", "Target Organism": "Bacillus subtilis 168(MIC=>200µM),Staphylococcus aureus(MIC=>200µM),Pseudomonas aeruginosa(MIC=>200µM),Escherichia coli DH5alpha(MIC=>200µM),Human cervical carcinoma HeLa(IC50=44.31±15.45µM),Human colon adenocarcinoma HCT 116(IC50=177.87±18.76µM),Human lung carcinoma A549(IC50=>200µM)"}}}